Table 5 Number of children 15–30 kg at risk of subcutaneous injection (STMDmax and STMDmin) or periosteal or bone injection (STBDmax and STBDmin)
| Brand |
Needle length mm | STMDmin | STMDmax |
STBD min |
STBD max |
|---|---|---|---|---|---|
|
EpipenJr® 0.15 mg Auvi-Q® 0.15 mg | |||||
| STBDmax | 12.7 | – | – | – | 11 |
| STMDmax | 10.7 | – | 1 | – | – |
| Jext® | |||||
| STBDmax | 15.7 | – | – | – | 38 |
| STMDmax | 13.7 | – | 0 | – | – |
| Emerade® 0.15 mg | |||||
| STBDmin | 16.0 | – | – | 0 | – |
| STMDmin | 14.0 | 0 | – | – | – |